Intel Capital led a round that will enable Exo, whose investors also include OSF HealthCare, Sony and Applied Materials, to improve its AI-powered ultrasound technology.
US-based medical imaging technology developer Exo Imaging emerged from stealth yesterday with a $35m series B round led by Intel Capital, the corporate venturing subsidiary of semiconductor producer Intel.
The company did not specify the participants in the series B round, but said its investors include healthcare provider OSF HealthCare, consumer electronics producer Sony’s Innovation Fund and Applied Ventures, the corporate venturing vehicle semiconductor equipment manufacturer Applied Materials.
The investor list was filled out by Wanxiang Healthcare Investments, the healthcare-focused…
